Hans Schreiber Selected Research

superagonist SIYR

1/2017	Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication.
8/2009	Recurrence of intracranial tumors following adoptive T cell therapy can be prevented by direct and indirect killing aided by high levels of tumor antigen cross-presented on stromal cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hans Schreiber Research Topics

Disease

56	Neoplasms (Cancer) 01/2022 - 10/2002
4	Neoplasm Metastasis (Metastasis) 01/2020 - 08/2007
2	Carcinogenesis 11/2020 - 12/2004
2	Carcinoma (Carcinomatosis) 01/2020 - 08/2007
1	Body Weight (Weight, Body) 01/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Adenocarcinoma 01/2016
1	Melanoma (Melanoma, Malignant) 08/2013
1	Bites and Stings (Sting) 09/2012
1	Leukemia 02/2012
1	Autoimmune Diseases (Autoimmune Disease) 08/2010
1	Brain Neoplasms (Brain Tumor) 08/2009
1	Fibrosarcoma 12/2006
1	Inflammation (Inflammations) 12/2004
1	Venezuelan Equine Encephalomyelitis 10/2002

Drug/Important Bio-Agent (IBA)

33	AntigensIBA 01/2022 - 12/2002
12	Neoplasm Antigens (Tumor Antigens)IBA 06/2016 - 12/2002
9	Peptides (Polypeptides)IBA 01/2020 - 06/2005
8	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 01/2007
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2003
6	Chimeric Antigen ReceptorsIBA 12/2021 - 09/2012
6	EpitopesIBA 01/2020 - 10/2002
6	Monoclonal AntibodiesIBA 01/2019 - 10/2006
6	CytokinesIBA 11/2013 - 03/2004
5	GlycopeptidesIBA 01/2020 - 06/2010
4	Glycoproteins (Glycoprotein)IBA 01/2020 - 08/2007
3	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2017
3	Polysaccharides (Glycans)IBA 01/2020 - 10/2006
3	AutoantigensIBA 01/2016 - 12/2003
2	CarcinogensIBA 11/2020 - 12/2004
2	Threonine (L-Threonine)FDA Link 01/2020 - 06/2010
2	AcetylgalactosamineIBA 01/2020 - 06/2010
2	Tn antigenIBA 01/2020 - 06/2010
2	Surface Antigens (Surface Antigen)IBA 01/2020 - 01/2016
2	Serine (L-Serine)FDA Link 01/2020 - 06/2010
2	CarbohydratesIBA 01/2020 - 06/2010
2	superagonist SIYRIBA 01/2017 - 08/2009
2	RNA (Ribonucleic Acid)IBA 01/2016 - 10/2002
2	Pharmaceutical PreparationsIBA 12/2014 - 01/2007
2	LigandsIBA 12/2013 - 02/2012
2	Interleukin-15 (Interleukin 15)IBA 05/2013 - 04/2012
2	Histocompatibility Antigens Class IIBA 05/2012 - 06/2011
2	PerforinIBA 04/2012 - 04/2008
2	Interferon-gamma (Interferon, gamma)IBA 06/2011 - 03/2005
2	VaccinesIBA 06/2010 - 10/2002
2	AntibodiesIBA 04/2003 - 01/2003
2	Immunoglobulin G (IgG)IBA 04/2003 - 01/2003
1	Indicators and Reagents (Reagents)IBA 12/2021
1	Estrogens (Estrogen)FDA Link 11/2020
1	CalciumIBA 01/2020
1	SugarsIBA 01/2020
1	Tartrate-Resistant Acid PhosphataseIBA 01/2020
1	LyP-1 peptideIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	Death Domain ReceptorsIBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Isoantigens (Alloantigen)IBA 01/2017
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2016
1	CollagenIBA 01/2016
1	NucleotidesIBA 01/2016
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2016
1	Collagen Type I (Type I Collagen)IBA 01/2016
1	Cancer VaccinesIBA 01/2014
1	Blocking AntibodiesIBA 08/2013
1	Bacterial VaccinesIBA 08/2013
1	polyvinylsiloxane caoutchoucIBA 11/2012
1	SialomucinsIBA 09/2012
1	Single-Chain AntibodiesIBA 09/2012
1	T-Cell Antigen Receptor-CD3 ComplexIBA 09/2012
1	DEAD-box RNA HelicasesIBA 05/2012
1	Interleukin-15 Receptors (Interleukin 15 Receptor)IBA 04/2012
1	I-antigenIBA 06/2011
1	RibonucleoproteinsIBA 08/2010
1	Ribosomal Proteins (Ribosomal Protein)IBA 08/2010
1	OligosaccharidesIBA 06/2010
1	MonosaccharidesIBA 10/2006
1	GlycosyltransferasesIBA 10/2006
1	Mutant Proteins (Protein, Mutant)IBA 10/2006
1	Fas Ligand Protein (Fas Ligand)IBA 12/2004
1	InterferonsIBA 12/2004
1	Interleukin-6 (Interleukin 6)IBA 12/2004
1	Interleukin-12 (IL 12)IBA 03/2004
1	Interleukin-18 (Interleukin 18)IBA 03/2004
1	ChemokinesIBA 02/2004
1	Tamoxifen FDA LinkGeneric 04/2003
1	HLA-A*02:01 antigenIBA 10/2002
1	DNA (Deoxyribonucleic Acid)IBA 10/2002

Therapy/Procedure

18	Therapeutics 12/2021 - 10/2006
14	Immunotherapy 01/2022 - 12/2003
1	Lymph Node Excision (Lymph Node Dissection) 01/2020
1	Injections 09/2012
1	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2012
1	Drug Therapy (Chemotherapy) 08/2007
1	Aftercare (After-Treatment) 01/2007
1	Ligation 12/2006